Detalhe da pesquisa
1.
Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.
Blood
; 118(16): 4384-93, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21865345
2.
Low booster uptake in cancer patients despite health benefits.
medRxiv
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961284
3.
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.
Cancer Cell
; 2(2): 117-25, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12204532
4.
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.
J Clin Invest
; 117(9): 2562-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17710227
5.
Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia.
Leuk Res
; 32(5): 823-7, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17915315
6.
Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery.
Exp Hematol
; 30(4): 374-80, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11937274
7.
Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
Oncology (Williston Park)
; 16(9 Suppl 10): 153-61, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12380966
8.
Somatic SETBP1 mutations in myeloid malignancies.
Nat Genet
; 45(8): 942-6, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23832012
9.
Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors.
Cancer Genet
; 204(7): 392-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21872826
10.
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion.
Cancer
; 116(2): 377-86, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924787
11.
Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.
Leuk Res
; 34(6): 708-13, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19804904
12.
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
J Clin Oncol
; 27(27): 4563-9, 2009 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19652059
13.
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
J Clin Oncol
; 27(36): 6109-16, 2009 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19901108
14.
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.
J Exp Med
; 205(3): 585-94, 2008 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18299402
15.
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
J Clin Oncol
; 26(19): 3204-12, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18541900
16.
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics.
Blood
; 108(12): 3674-81, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16902153
17.
Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience.
Blood
; 100(2): 435-41, 2002 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12091333
18.
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.
Blood
; 99(10): 3530-9, 2002 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11986204